Clinical Trial Update: Isolated Limb Infusion Chemotherapy With Targeted Gene Therapy for Advanced, Unresectable Extremity Melanoma [Phase 1, Phase 2]

View source ↗

Summary

The clinical trial investigating isolated limb infusion chemotherapy with targeted gene therapy for advanced, unresectable extremity melanoma has been withdrawn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Washington University School of Medicine | Conditions: Melanoma | Phase 1, Phase 2 | Status: WITHDRAWN